| Scott D Rebhun, MD | |
|
215 N Main St, Va Medical Center, White River Junction, VT 05009-0001 | |
| (802) 295-9363 | |
| Not Available |
| Full Name | Scott D Rebhun |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 215 N Main St, White River Junction, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700972569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 9047 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Scott D Rebhun, MD 215 N Main St, Va Medical Center, White River Junction, VT 05009-0001 Ph: (802) 295-9363 | Scott D Rebhun, MD 215 N Main St, Va Medical Center, White River Junction, VT 05009-0001 Ph: (802) 295-9363 |
News Archive
New research has found that in 15 major cities in the global south, almost half of all households lack access to piped utility water, affecting more than 50 million people
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O'Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.
Somanetics Corporation has announced a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the labeling for its INVOS(R) Cerebral/Somatic Oximeter.
UT Southwestern Medical Center researchers have identified a possible therapy to treat neurofibromatosis type 1 or NF1, a childhood neurological disease characterized by learning deficits and autism that is caused by inherited mutations in the gene encoding a protein called neurofibromin.
Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, is pleased to announce the launch and availability of an innovative software platform called Darwin for conducting population pharmacokinetic (PK) analyses based on a genetic algorithm paradigm.
› Verified 2 days ago
Dr. John L Hammel, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, Va Medical Center, Mental Health Department, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-6342 | |
Dr. Andrew S. Pomerantz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, Mental Health 116a, White River Junction, VT 05001 Phone: 802-295-9363 Fax: 802-296-6389 | |
Stephen Bettwieser, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-5188 | |
Lisa Ann Lambert, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 | |
Dr. Linda M Nagy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, Vamc 116a, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-6389 | |
Melissa Moate Ley-thomson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 | |
Dr. Jonathan Carl Schwartz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-6342 |